Here, differences in the function and spatial organization between tumor-infiltrating CD4+PD1+ T cells, Tregs, and malignant CD4+ T cells were correlated with the treatment response of CTCL patients. This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.